Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home News

Dean Baker Debates Bob Murphy on Recession Outlook

by
December 23, 2023
in News
0
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On a recent installment of the Pynx debate series, Bob had a friendly debate with Dean Baker on a soft or hard landing in 2024. In this episode of the Human Action Podcast, Bob comments on the key disputes, underlying the differences between the Austrian and Keynesian frameworks.

Bob’s Debate with Dean Baker: Mises.org/HAP427a
Bob’s Paper on the Inverted Yield Curve: Mises.org/HAP427b
 
Join Tom DiLorenzo, Joe Salerno, and Patrick Newman in Tampa on February 17: Mises.org/Tampa2024
Use code “Action24” for 15% off admission.

Human Action Podcast listeners can get a free copy of Murray Rothbard’s Anatomy of the State: Mises.org/HAPodFree

Previous Post

Authorities in Jamaica Endorse Cancel Culture

Next Post

Argentina Is One of the Most Regulated Countries in the World

Next Post
Argentina Is One of the Most Regulated Countries in the World

Argentina Is One of the Most Regulated Countries in the World

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021
Pints of champagne could be the next ‘Brexit dividend’

Pints of champagne could be the next ‘Brexit dividend’

December 24, 2021
Who Deserves a Cure? The FDA’s New Gatekeeping Game

Who Deserves a Cure? The FDA’s New Gatekeeping Game

0

0

0

0
Who Deserves a Cure? The FDA’s New Gatekeeping Game

Who Deserves a Cure? The FDA’s New Gatekeeping Game

July 18, 2025

Top Polish retailers plan to join EMD, the premier buying and marketing group in Europe

July 18, 2025
Company insolvencies fall in England and Wales, but experts warn challenges remain

Company insolvencies fall in England and Wales, but experts warn challenges remain

July 18, 2025
Netflix turns to generative AI for visual effects in original series The Eternauts

Netflix turns to generative AI for visual effects in original series The Eternauts

July 18, 2025

Recent News

Who Deserves a Cure? The FDA’s New Gatekeeping Game

Who Deserves a Cure? The FDA’s New Gatekeeping Game

July 18, 2025

Top Polish retailers plan to join EMD, the premier buying and marketing group in Europe

July 18, 2025
Company insolvencies fall in England and Wales, but experts warn challenges remain

Company insolvencies fall in England and Wales, but experts warn challenges remain

July 18, 2025
Netflix turns to generative AI for visual effects in original series The Eternauts

Netflix turns to generative AI for visual effects in original series The Eternauts

July 18, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.